Acetaldehyde, the major ethanol metabolite that is far more toxic and reactive than ethanol, has been postulated to be responsible for alcohol-induced tissue and cell injury. This study was to examine whether facilitated acetaldehyde metabolism affects acetaldehyde-induced oxidative stress and apoptosis. Transgene-encoding human aldehyde dehydrogenase-2 (ALDH2), which converts acetaldehyde into acetate, was constructed under chicken ␤-actin promoter and transfected into human umbilical vein endothelial cells (HUVECs). Efficacy of ALDH2 transfection was verified using green fluorescent protein and ALDH2 enzymatic assay. Generation of reactive oxygen species (ROS) was measured using chloromethyl-2,7-dichlorodihydrofluorescein diacetate. Apoptosis was evaluated by 4,6-diamidino-2-phenylindoladihydrochloride fluorescence microscopy, quantitative DNA fragmentation, and caspase-3 assay. Acetaldehyde (0 -200 M) elicited ROS generation and apoptosis in HUVECs in a time-and concentration-dependent manner, associated with activation of the stress signal molecules ERK1/2 and p38 mitogen-activated protein (MAP) kinase. A close liner correlation was observed between the acetaldehyde-induced ROS generation and apoptosis. Interestingly, the acetaldehydeinduced ROS generation, apoptosis, activation of ERK1/2, and p38 MAP kinase were prevented by the ALDH2 transgene or antioxidant ␣-tocopherol. The involvement of ERK1/2 and p38 MAP kinase in acetaldehyde-induced apoptosis was confirmed by selective kinase inhibitors U0126, SB203580, and SB202190. Collectively, our data revealed that facilitation of acetaldehyde metabolism by ALDH2 transgene overexpression may prevent acetaldehyde-induced cell injury and activation of stress signals. These results indicated therapeutic potential of ALDH2 enzyme in the prevention and detoxification of acetaldehyde or alcohol-induced cell injury.
Chronic alcohol consumption leads to cardiovascular complications such as endothelial dysfunction and alcoholic cardiomyopathy (1) . Although several hypotheses have been speculated for alcohol-induced injury including direct/indirect toxicity of alcohol and accumulated fatty acid ethyl esters (2, 3) , neither scenario has been fully validated by compelling clinical and experimental evidence. Acetaldehyde is the very first oxidized metabolic product of ethanol and is considered a candidate toxin for alcohol-induced tissue and cell injury. It is far more reactive than ethanol and may inhibit protein synthesis (4, 5) . Our laboratory (6 -8) has shown that acetaldehyde interrupts cardiac excitation-contraction coupling and sarco(endo)plasmic reticulum Ca 2ϩ release function. Acetaldehyde has also been shown to form protein adducts leading to atherosclerotic vascular injury (9) . Transgenic mice with cardiac overexpression of alcohol dehydrogenase (ADH) 1 displayed higher cardiac acetaldehyde levels associated with compromised heart function at whole heart and ventricular myocyte levels following alcohol intake (10 -12) , suggesting that acetaldehyde may be one of the major culprits for alcoholic cardiomyopathy and possibly other alcoholic complications. Blood acetaldehyde levels may reach low millimolar range following alcohol intake in Asians and African Americans due to defective aldehyde dehydrogenase (ALDH) (13, 14) , making these populations at higher risk for alcohol-induced tissue and cell injury. To further elucidate the culprit role of acetaldehyde in tissue and cell damage, our present study was designed to produce a transgene construct-encoding human ALDH type 2 isozyme (ALDH2) to be overexpressed in human umbilical vein endothelial cells (HUVECs). Our hypothesis was that the ALDH2 transgene should speed up the breakdown (and detoxification) of the toxin acetaldehyde and thus alleviate oxidative stress and apoptosis resulted from acetaldehyde exposure.
MATERIALS AND METHODS
HUVEC Cell Culture-Confluent human HUVECs (ATCC, Manassas, VA) were maintained in Kaighn's F-12K medium containing 2 mM Lglutamine, 1.5 g/liter sodium bicarbonate, 0.1 mg/ml heparin, 0.05 mg/ml endothelial cell growth supplement, and 10% fetal bovine serum at 37°C with 5% CO 2 . HUVECs were incubated with acetaldehyde (0 -200 M) for 0 -48 h before oxidative stress and apoptosis were measured.
Generation of the ALDH2 Transgene Construct and Its Expression in
HUVECs-The human ALDH2 gene was amplified by PCR from pT7-7-hpALDH2 (provided by Dr. Henry Weiner from Purdue University, Lafayette, IN) using the following primers: ALDH-F (5Ј-tcgaattctatgttgcgcgctgccgcccg) and ALDH-R (3Ј-cacggagtcttcttgagtattcttaaggc). The amplified ALDH2 fragment was digested with EcoRI and cloned into the EcoRI site of vector pBsCAG-2 under the CAG cassette, which was shown to drive expression in many mammalian tissues (15) . The transgene construct was designated as pCAG-ALDH2 (Fig. 1) . The ALDH2 gene under the CAG cassette control was cloned into plasmid enhanced green fluorescent protein (pEGFP)-C1 (Clontech Laboratories, Inc., Palo Alto, CA) using a combination of KpnI ϩ BamHI to construct the plasmid pGFP-CAG-ALDH2. Either pCAG-ALDH2 or pGFP-CAG-ALDH2 containing the ALDH2 gene were transfected into HUVECs using LipofectAMINE (Invitrogen).
Enzymatic Activity Assay for ALDH2 Transgene-Expression of ALDH2 in HUVECs following 24 h of incubation at 37°C was confirmed by an enzymatic assay (16) . In brief, HUVEC extracts were prepared by sonication in 9 volumes of 0.1 M sodium phosphate (pH 7.0). The ALDH2 enzymatic activity was measured at 25°C in 1 ml of 33 mM sodium pyrophosphate (pH 8.8) containing 0.8 mM NAD ϩ , 15 M propionaldehyde, and 0.1 ml of cell extract (50 g of soluble protein). Production of NADH was determined by absorbance intensity at 340 nm obtained every 50 ms for 5-10 min using a Beckman spectrophotometer (model DU-62) equipped with a kinetics software module. Only the linear portion of ALDH activity curve was used for enzymatic activity analysis. 
Intracellular Fluorescence Measurement of Intracellular Reactive Oxygen Species (ROS)-
The membrane-permeable probe 5-(6)-chloromethyl-2Ј,7Ј-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA) (Molecular Probes, Eugene, OR) enters the cells and produces a fluorescent signal after intracellular oxidation by ROS. Intracellular oxidative stress was monitored by both microscopic observation of the changes in fluorescence intensity according to our previously described method (17) and measurement of intracellular fluorescence intensity in a Spectra MaxGeminiXS molecular device (Spectra Max, Alanta, GA) at an excitation wavelength of 485 nm and an emission wavelength of 530 nm (18) . In microscopic observation, HUVECS were loaded with 1 M CM-H 2 DCFDA for 30 min at 37°C and washed with phosphate-buffered saline buffer. Cells were sampled randomly using an Olympus IX-70 microscope equipped with a digital cooled charged-coupled device camera and ImagePro image analysis software (Media Cybernetics, Silver Spring, MD). Fluorescence was calibrated with InSpeck microspheres (Molecular Probes). More than 500 cells were evaluated in more than five visual fields. For measurement of intracellular fluorescence intensity using the Spectra MaxGeminiXS molecular device, 200 l of cells (ϳ10 5 cells/ml) were loaded with 10 M CM-H 2 DCFDA for 45 min at 37°C, and intracellular fluorescence intensity was analyzed in a along periphery of nucleus, and segmentation of nucleus. In brief, HUVECs were fixed with 4% paraformaldehyde and then washed with phosphate-buffered saline. 4Ј,6Ј-Diamidino-2Ј-phenylindoladihydrochloride (DAPI, 1 g/ml) was added to the fixed HUVECs for 30 min, after which they were examined by Olympus IX-70 fluorescence microscope equipped with a digital cooled charged-coupled device camera and ImagePro image analysis software (Media Cybernetics). For quantitative assay, determination of cytoplasmic histone-associated DNA fragments was performed using a cell death detection enzyme-linked immunosorbent assay kit (Roche Applied Science, Mannheim, Germany).
Caspase-3 Assay-The caspase-3 activity was determined according to the published method (19) . Briefly, 1 ml of phosphate-buffered saline was added to a flask containing HUVECs, and the monolayer was scraped and collected in a microcentrifuge tube. HUVECs were pelleted by centrifugation at 10,000 ϫ g at 4°C for 10 min. The supernatant was discarded, and HUVECs were lysed in 100 l of ice-cold cell lysis buffer (50 mM HEPES (pH 7.4), 0.1% CHAPS, 1 mM dithiothreitol), 0.1 mM EDTA, 0.1% Nonidet P-40). The assay was carried out in a 96-well plate with each well containing 30 l of cell lysate, 70 l of assay buffer (50 mM HEPES, 0.1% CHAPS, 100 mM NaCl, 10 mM dithiothreitol, and 1 mM EDTA) and 20 l of caspase-3 colorimetric substrate Ac-DEVD-pnitroanilide (Sigma). The 96-well plate was incubated at 37°C for 1 h, during which time the caspase in the sample was allowed to cleave the chromophore p-nitroanilide from the substrate molecule. Absorbency was detected at 405 nm with caspase-3 activity being proportional to color reaction. Protein content was determined using the Bradford method (39). The caspase-3 activity was expressed as picomoles of p-nitroanilide released per micrograms of protein per minute.
Western Analysis of Extracellular Signal-regulated Kinase (ERK1/2) and p38 Mitogen-activated Protein (MAP) Kinase-HUVECs were sonicated in a lysis buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 0.1% SDS, and protease inhibitor mixture. Equal amount of lysates (50 g/lane) were separated on 20% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes. The membranes were blocked in 5% (w/v) nonfat milk and then incubated with anti-ERK1/2 (1:2000), anti-phospho-ERK1/2 (1: 1000), anti-p38 MAP kinase (1:2000) , and anti-phospho-p38 MAP kinase (1:1000) antibodies. Anti-ERK1/2 and anti-phospho-ERK1/2 monoclonal antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), whereas anti-p38 MAP kinase and anti-phospho-p38 MAP kinase polyclonal antibodies were purchased from Cell Signaling Technology (Beverly, MA). The antigens were detected by the luminescence method (ECL Western blotting detection kit, Amersham Biosciences) with peroxidase-linked anti-mouse (phospho-ERK1/2) or antirabbit (ERK1/2, p38 MAP kinase, and phospho-p38 MAP kinase) IgG (1:5000 dilution). The intensity of immunoblot bands was detected with a Bio-Rad Calibrated Densitometer (model GS-800) (20) .
Data Analysis-Data are mean Ϯ S.E. Statistical significance (p Ͻ 0.05) was determined by analysis of variance with a Dunnetts post hoc test.
RESULTS

Verification of ALDH Enzymatic Activity following Transgene Overexpression of ALDH2-
The transfection efficacy of the ALDH2 construct pCAG-ALDH2 (Fig. 1) , following 24 h of incubation with HUVECs, was evaluated using similar construct expressing EGFP (pGFP-CAG-ALDH). The transfection efficiency by pCAG-ALDH2 (ϳ90%) was determined by ratio of fluorescence microscopic count of GFP expression to the light microscopic images of total cells (Fig. 2, A-F) . Transfection of ALDH2 significantly enhanced the enzymatic activity of ALDH in HUVECs. Control HUVEC cells, i.e. either nontransfected or transfected with CAG vector only, exhibited minimal levels of ALDH activity (Fig. 2G) . Fig. 3A demonstrates that acetaldehyde induced intracellular ROS generation and caspase-3 activation in a time-and concentration-dependent manner. While 50 M acetaldehyde failed to elicit any effect on caspase-3 activity and enhanced intracellular ROS generation only after 24 h of incubation, higher concentrations of acetaldehyde (100 and 200 M) required much shorter duration (4 -8 h and 2 h, respectively) to significantly enhance ROS generation and caspase-3 activation. Acetaldehyde-induced ROS generation and caspase-3 activation appeared to reach a plateau phase by 12 and 24 h, respectively, suggesting a possible sequential order between the two. To further evaluate the correlation between ROS generation and apoptosis, DNA fragmentation was quantitated in acetaldehyde (100 M)-treated HUVEC samples the ROS generation of which was predetermined at different incubation time points. A tight liner regression (r 2 ϭ 0.939) curve was achieved when the DNA fragmentation was plotted against respective ROS generation from the same sample (Fig. 3B) , indicating high correlation between oxidative stress and apoptosis in response to acetaldehyde exposure.
Time-dependent Effect of Acetaldehyde on Oxidative Stress and Apoptosis in HUVECs-
Protection of Acetaldehyde-induced Oxidative Stress and Apoptosis by ALDH2 and Antioxidant-The panels in Fig. 4 illustrated that 24-h incubation of acetaldehyde (100 M) significantly enhanced CM-H 2 DCFDA fluorescent intensity in nontransfected HUVECs or cells transfected with pCAG vector only. Interestingly, ALDH2 transfection or the antioxidant ␣-tocopherol (5 g/ml) prevented an acetaldehyde-induced rise in ROS generation, suggesting that either facilitation of acetaldehyde metabolism or antioxidant may alleviate its cellular toxicity (Fig. 4) .
Consistent with the results on intracellular ROS generation, the number of DAPI-stained fluorescent cells (indicative of apoptosis) was significantly higher after 24-h incubation of acetaldehyde (100 M) with nontransfected HUVECs (Fig. 5C ) or cells transfected with vector pCAG only (Fig. 5D) . Apoptotic characteristics were detected in Fig. 5 , C and D, including nuclear condensation. In contrast, such change did not occur in HUVECs overexpressing ALDH2 transgene or those treated with the antioxidant ␣-tacopherol (5 g/ml), indicating protection against acetaldehyde-induced cell death (Fig. 5, E and F) . This notion was supported by other apoptotic assay including DNA fragmentation (Fig. 5G ) and caspase-3 assay (Fig. 6 ). vector only displayed minimal DAPI fluorescence in the absence of acetaldehyde exposure (Fig. 5, A and B) , indicating that the pCAG vector itself may not be innately harmful.
Western Blot Analysis of the Stress Signal Molecules ERK1/2 and p38 MAP Kinase-To elucidate the signaling pathway(s) involved in ALDH2-elicited cytoprotection against acetaldehydeinduced oxidative stress and apoptosis, we examined the phosphorylation of the stress signal molecules ERK1/2 and p38 MAP kinase in HUVECs in response to acetaldehyde exposure. As shown in Fig. 7 , Western blot analysis revealed that 8-h incubation of acetaldehyde (100 M) led to elevated phosphorylation of both ERK1/2 and p38 MAP kinase in nontransfected cells or HUVECs transfected with CAG vector only. Interestingly, transfection of ALDH2 transgene abolished acetaldehyde-elicited activation of ERK1/2 and p38 MAP kinase. Neither the pCAG vector nor acetaldehyde affected total ERK1/2 or p38 MAP kinase levels (data not shown). The antagonism of ALDH2 transgene against acetaldehyde-induced ERK1/2 and p38 MAP kinase activation may play a significant role in ALDH2-offered cytoprotection and is consistent with the notion regarding involvement of these two stress signaling molecules in acetaldehyde-induced cell injury (21, 22) . To further verify the role of ERK1/2 and p38 MAP kinase in acetaldehyde-induced cell injury, the specific ERK1/2 inhibitor U0126 (2.5 M), the p38 MAP kinase inhibitors SB203580 (2.5 M) and SB202190 (2.5 M), along with their inactive analogue SB202474 (2.5 M) were incubated with HU- VECs in the presence of acetaldehyde. Results in Fig. 8 indicated that U0126 and SB203580, either alone or in combination, significantly attenuated the acetaldehyde-induced caspase-3 activation and DNA fragmentation in HUVECs over incubation durations between 0 and 24 h. However, no additive or synergistic effect was observed when both pathways were blocked. SB202190 duplicated the effect of SB203580, whereas their inactive analogue SB202474 displayed little effect on acetaldehydeinduced apoptosis.
DISCUSSION
Our major finding revealed that overexpression of ALDH2 transgene prevented acetaldehyde-induced oxidative stress, activation of critical stress signaling molecules ERK1/2 and p38 MAP kinase, as well as apoptosis in HUVECs. The ALDH2 elicited cytoprotection against acetaldehyde-induced cell injury is somewhat similar to ␣-tacopherol, suggesting a possible antioxidant property of ALDH2 transgene. These results not only suggested a role of acetaldehyde as a critical culprit in ethanolinduced cell damage through a stress signaling (ERK1/2 and p38 MAP kinase)-mediated mechanism but also provided convincing evidence that ALDH2 may be a key therapeutic target/ tool for the prevention and treatment of alcohol-or acetaldehyde-induced tissue and cell injury.
The major novelty of the present study is that the newly constructed ALDH2 transgene should provide a useful tool to artificially modify the acetaldehyde metabolism, in conjunction with ADH transgene reported earlier (10, 11) . The availability of both transgenes has made it possible to examine the precise mechanism(s) of acetaldehyde in alcoholic tissue and cell injury. Although several hypotheses have been postulated for alcohol toxicity including oxidative damage, lipid peroxidation and altered membrane property due to hydrophobic ethanol interaction with membrane components (23) (24) (25) , the culprit toxin in alcoholic tissue and cell injury, has not been clearly identified and thus hindered proper treatment and prevention of alcoholic complications. Ethanol has been demonstrated to contribute to oxidative stress and enhanced peroxidation of lipids, protein, and DNA in a wide variety of organs, tissues, and cells (23) (24) (25) (26) . Similarly, the ethanol metabolite acetaldehyde directly enhances free radical generation by its oxidation via aldehyde oxidase and/or xanthine oxidase with concurrent accumulation of superoxide (25, (27) (28) (29) . It is thus reasonable to postulate that the toxic effects of ethanol may be, at least in part, mediated through acetaldehyde. This hypothesis received convincing support from our recent observations of exacerbated cardiac mechanical dysfunction, oxidative stress, and lipid peroxidation associated with a parallel increase in serum and cardiac acetaldehyde levels following acute or chronic alcohol exposure in mice with cardiac specific overexpression of ADH (11, 12) . These data suggest not only a key role of acetaldehyde in alcoholic cardiomyopathy but also free radical formation in alcohol-and acetaldehyde-induced cardiac damage. Evidence from our laboratory and others (30, 31) also indicated that the acetaldehyde-induced cellular toxicity is mediated through the ethanol-inducible isoform of cytochrome P-450, namely CYP2E1, xanthine oxidase and aldehyde oxidase. Inhibition of these enzymatic pathways significantly reduces acetaldehydeinduced lipid peroxidation, tissue and cell injury (31) . Metabolism of acetaldehyde through these enzymatic pathways may play an important role in oxidative stress leading to cellular pathology under alcoholism. In addition to the potential interactions with xanthine oxidase, aldehyde oxidase, and CYP2E1, acetaldehyde is capable of stimulating peroxidative reactions by depleting cellular reduced glutathione (32). It has been shown that inhibition of ADH prevents, whereas inhibition of ALDH potentiates, the decrease in reduced glutathione levels resulted from ethanol intake (33) . Protein-adduct formation between acetaldehyde and the glutathione precursor, L-cysteine, may contribute to glutathione depletion (34) .
Data from our current study revealed that ALDH2 transgene protects acetaldehyde-induced apoptosis is mediated, at least in part, through ERK1/2 and p38 MAP kinase stress signaling pathways. This is consistent with earlier reports of the involvement of ERK1/2 and MAP kinase cascade in acetaldehydeinduced cell toxicity (21, 22) or chronic alcohol ingestion-related oxidative injury (35, 36) . Acetaldehyde as a highly reactive product from the oxidative metabolism of ethanol was shown to be a critical mediator of ethanol-induced apoptosis via the activation of MAP kinase signaling cascade (21, 37, 38) . Our result of concurrent inhibition of ERK1/2 and p38 MAP kinase displaying no additive or synergistic effect on acetaldehyde-induced apoptosis may indicate a likely "shared" downstream pathway between the two stress signal molecules. Furthermore, our observation that inhibition of either pathway (or both) failed to fully prevent the acetaldehyde-induced apoptosis (no effect at all on DNA fragmentation at 8-h incubation point) suggests existence of other signaling pathways in acetaldehyde-induced apoptosis. Further study is warranted to elucidate the precise stress signaling mechanisms involved in the acetaldehyde-induced cell toxicity and ALDH2 transgene offered protection.
In summary, our study provided evidence that overexpression of ALDH2 in HUVECs significantly lessens acetaldehydeinduced oxidative stress, activation of stress signaling, and apoptosis in a manner similar to antioxidant ␣-tacopherol, suggesting the therapeutic value of ALDH2 in detoxification of acetaldehyde, which is essential in the management and prevention of alcohol-related tissue and cell injury. Future work should focus on accessing the clinical feasibility of ALDH2 transgene in the management of alcoholic complications, which would require a better understanding the links between acetaldehyde and cell death in the onset and development of alcoholic complications.
